...
机译:术前胆红素调整后血清碳水化合物抗原19-9在胆管癌179例患者多中心子集分析中的预后相关性
Univ Hosp Schleswig Holstein Surg Clin Campus Lubeck Lubeck Germany;
Univ Hosp Schleswig Holstein Surg Clin Campus Lubeck Lubeck Germany;
Tech Univ Dresden Univ Hosp Dept Visceral Thorac &
Vasc Surg Dresden Germany;
Univ Med Ctr Mannheim Dept Surg Mannheim Germany;
Univ Med Ctr Freiburg Dept Gen &
Visceral Surg Freiburg Germany;
Univ Med Ctr Freiburg Dept Gen &
Visceral Surg Freiburg Germany;
Univ Hosp Schleswig Holstein Surg Clin Campus Lubeck Lubeck Germany;
Univ Freiburg Med Ctr Inst Surg Pathol Freiburg Germany;
Municipal Hosp Neumarkt Dept Gen Visceral &
Thorac Surg Neumarkt Germany;
Moscow Clin Sci Ctr Moscow Russia;
Univ Hosp Schleswig Holstein Surg Clin Campus Lubeck Lubeck Germany;
Univ Hosp Schleswig Holstein Surg Clin Campus Lubeck Lubeck Germany;
Univ Hosp Schleswig Holstein Surg Clin Campus Lubeck Lubeck Germany;
Tech Univ Dresden Univ Hosp Dept Visceral Thorac &
Vasc Surg Dresden Germany;
机译:术前胆红素调整后血清碳水化合物抗原19-9在胆管癌179例患者多中心子集分析中的预后相关性
机译:术前胆红素调节的碳水化合物抗原19-9作为单一中心脱毛胆管癌患者的预后因素
机译:Ⅳ期大肠癌患者术前血清糖抗原19-9的预后意义
机译:原发性乳腺癌患者术前血清CA15-3,CEA和TPS水平的临床和预后意义
机译:术前胆红素调整的碳水化合物抗原19-9作为单一中心肝外胆管癌患者的预后因素
机译:结直肠癌患者治疗前血清糖类抗原19-9水平的预后价值:荟萃分析。